TrialAmerican journal of hematology2019

Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts.

Paolo Strati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.